Identification of specific Y chromosomes associated with increased prostate cancer risk.
- Published in:
- Prostate, 2014, v. 74, n. 9, p. 991, doi. 10.1002/pros.22821
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 2014 AND VI 74 AND IP 9
Results: 8
1
2
Notch signaling in prostate cancer: A moving target.
- Published in:
- Prostate, 2014, v. 74, n. 9, p. 933, doi. 10.1002/pros.22811
- By:
- Publication type:
- Article
3
Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues.
- Published in:
- Prostate, 2014, v. 74, n. 9, p. 923, doi. 10.1002/pros.22810
- By:
- Publication type:
- Article
4
Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia.
- Published in:
- Prostate, 2014, v. 74, n. 9, p. 970, doi. 10.1002/pros.22814
- By:
- Publication type:
- Article
5
Identification of a novel germline SPOP mutation in a family with hereditary prostate cancer.
- Published in:
- Prostate, 2014, v. 74, n. 9, p. 983, doi. 10.1002/pros.22818
- By:
- Publication type:
- Article
6
Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer.
- Published in:
- Prostate, 2014, v. 74, n. 9, p. 959, doi. 10.1002/pros.22813
- By:
- Publication type:
- Article
7
KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells.
- Published in:
- Prostate, 2014, v. 74, n. 9, p. 946, doi. 10.1002/pros.22812
- By:
- Publication type:
- Article
8
MS4A8B promotes cell proliferation in prostate cancer.
- Published in:
- Prostate, 2014, v. 74, n. 9, p. 911, doi. 10.1002/pros.22802
- By:
- Publication type:
- Article